Immunohistochemical positivity for CK7 and MUC5AC and negativity for TTF-1 and p63 aid in differentiating MEC from adenosquamous carcinoma and metastatic lesions [7]. This evidence concerns the gene KRT7 and adenosquamous carcinoma.